+1 973 564 7555 [email protected]
ISO 13485:2016   MDSAP 3277299-150
Global Offices:
  • U.S.
  • Germany
  • Russia
    • Moscow
    • Saint Petersburg
  • Poland
  • Czech Republic
0 Items
DRG International, Inc.
  • Products
    • Product Store
    • FDA Cleared ELISAs
    • DRG:HYBRiD-XL®
    • Hepcidin 25 (bioactive) HS
    • Salivary ELISA Kits
    • CHROMagar
    • RUO ELISAs
    • Health Canada Registered
    • Ameritox Labs
  • Distribution
  • Newsroom
    • News
    • Media
    • Events
  • Reference Library
  • About Us
    • General Information
    • History Timeline
    • Personnel Profiles
  • Contact Us
  • Shop Now
Select Page
Early postnatal hypoferremia in low birthweight, preterm babies

Early postnatal hypoferremia in low birthweight, preterm babies

by Oleg Vishnevski | Jan 21, 2021 | Products | 0 comments

Early postnatal hypoferremia in low birthweight and preterm babies: A prospective cohort study in hospital-delivered Gambian neonates   Abstract Background Neonates, particularly those born preterm (PTB) and with low birthweight (LBW), are especially susceptible...
Early postnatal hypoferremia in low birthweight, preterm babies

Hepcidin exerts negative immunological effect in tuberculosis

by Oleg Vishnevski | Jan 19, 2021 | Products | 0 comments

Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture-negative   Highlights In contrast to HIV-related tuberculosis, evaluations of the influence of hepcidin in non-HIV-related...
Early postnatal hypoferremia in low birthweight, preterm babies

Hepcidin 25 HS & HIV Antiretroviral Therapy

by Oleg Vishnevski | Jan 12, 2021 | Products | 0 comments

Hepcidin 25 HS & HIV Antiretroviral Therapy Study   High levels of serum IL-6 and serum hepcidin and low CD4 cell count were risk factors of anemia of chronic disease in HIV patients on the combination of antiretroviral therapy.   Abstract Purpose: This...
Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis

Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis

by Oleg Vishnevski | Sep 30, 2020 | News, Products | 0 comments

Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis   Context: Severe energy deprivation markedly inhibits erythropoiesis by restricting iron availability for hemoglobin synthesis. Objective:...
Role of Hepcidin to Identify the Type of Anemia in Chronic Kidney Disease in Children

Role of Hepcidin to Identify the Type of Anemia in Chronic Kidney Disease in Children

by Oleg Vishnevski | Sep 24, 2020 | News, Products | 0 comments

Role of Hepcidin to Identify the Type of Anemia in Chronic Kidney Disease in Children See full study: https://iopscience.iop.org/article/10.1088/1742-6596/1246/1/012023/meta Abstract Chronic kidney disease (CKD) may present with anemia of chronic disease (ACD),...
Next Entries »

DRG International, Inc.

Global Headquarters
841 Mountain Avenue
Springfield, NJ 07081 USA

Tel: +1-973-564-7555
Fax: +1-973-564-7556

© Copyright 2022. All Rights Reserved.
PCI Compliance Certification

Subsidiaries

  • USA
  • Germany
  • Russia – Moscow
  • Russia – St Petersburg
  • Poland
  • Czech Republic

Support

  • Order Information
  • Troubleshooting

Shortcuts

 

 

 

  • Login
  • Terms of Use
  • Privacy Policy
  • Facebook
  • Twitter
  • linkedin
  • instagram

Designed by Walnut St. Labs